Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Judith Ben-Dror"'
Autor:
Didi Feldman, Liat Anabel Sinberger, Mali Salmon-Divon, Judith Ben-Dror, Shlomit Strulov Shachar, Amir Sonnenblick
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Purpose One-half of hormone receptor-positive (HR +) breast cancer (BC) patients have low expression of HER2 (HER2-low) and may benefit from trastuzumab deruxtecan (TDXd). This study aimed to identify parameters associated with HER2-low leve
Externí odkaz:
https://doaj.org/article/f1bcb80c6dcd410c82b259087f834674
Autor:
Yael Bar, Kfir Bar, Didi Feldman, Judith Ben- Dror, Meishar Shahoha, Shir Lerner, Shlomit Strulov Shachar, Ahuva Weiss-Meilik, Nachum Dershowitz, Ido Wolf, Amir Sonnenblick
Publikováno v:
Breast, Vol 77, Iss , Pp 103777- (2024)
Background: Early invasive ductal carcinoma (IDC) breast cancer often presents with a coexisting ductal carcinoma in situ (DCIS) component, while about 5 % of cases present with an extensive (>25 %) intraductal component (EIC). The impact of EIC on t
Externí odkaz:
https://doaj.org/article/4708491332944d729adf829736ab37a3
Autor:
Yael Bar, Kfir Bar, Judith Ben- Dror, Didi Feldman, Meishar Shahoha, Ahuva Weiss-Meilik, Nachum Dershowitz, Wolf Ido, Amir Sonnenblick
Publikováno v:
Cancer Research. 83:P3-05
Background: Invasive early breast cancer (IBC) often presents with a co-existing ductal carcinoma in situ (DCIS) component, while about 5% of the cases present with an extensive (>25%) intraductal component (EIC). The presence of a DCIS component was
Publikováno v:
Genes. 13:960
“The story of cancer is the story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception” (Siddhartha Mukherjee). The present review discusses the evolution of early breast cancer (BC) treatment philo